NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

391 hedge funds and large institutions have $9.56B invested in Neurocrine Biosciences in 2019 Q4 according to their latest regulatory filings, with 109 funds opening new positions, 137 increasing their positions, 103 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
391
Holders Change
+59
Holders Change %
+17.77%
% of All Funds
7.72%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
109
Increased
137
Reduced
103
Closed
41
Calls
$93.9M
Puts
$56.8M
Net Calls
+$37.1M
Net Calls Change
+$33.9M

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$79.5M
2
BlackRock
2
BlackRock
New York
$709M
3
State Street
3
State Street
Massachusetts
$264M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$784M
5
Ameriprise
5
Ameriprise
Minnesota
$36.6M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$786M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$793M
3
HM
3
HealthCor Management
New York
$86.7M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$6.35M
5
O
5
OrbiMed
New York
$101M
Name Holding Trade Value Shares
Change 		Shares
Change %
RPAM
76
Rhenman & Partners Asset Management
Sweden
$12.9M -$3.18M -29,600 -20%
EVM
77
Eaton Vance Management
Massachusetts
$12.7M -$1.72M -16,007 -12%
EAM
78
Erste Asset Management
Austria
$12.3M +$1.94M +18,000 +19%
Ensign Peak Advisors
79
Ensign Peak Advisors
Utah
$11.9M +$11.9M +110,848 New
CWM
80
CIBC World Markets
New York
$11.7M +$11.7M +109,300 New
State of Wisconsin Investment Board
81
State of Wisconsin Investment Board
Wisconsin
$11.3M +$9.89M +92,035 +719%
VanEck Associates
82
VanEck Associates
New York
$11.2M +$14.6K +136 +0.1%
RhumbLine Advisers
83
RhumbLine Advisers
Massachusetts
$10.8M +$285K +2,649 +3%
CSS
84
Cubist Systematic Strategies
Connecticut
$10.4M +$8.39M +78,073 +415%
AAMU
85
Amundi Asset Management US
Massachusetts
$10.2M +$3.03M +28,217 +42%
CM
86
Castleark Management
Illinois
$10.1M -$1.08M -10,058 -10%
RJA
87
Raymond James & Associates
Florida
$10.1M +$413K +3,842 +4%
GH
88
GAM Holding
Switzerland
$9.51M +$322 +3 +0%
Squarepoint
89
Squarepoint
New York
$9.08M -$8.73M -81,220 -49%
Lord, Abbett & Co
90
Lord, Abbett & Co
New Jersey
$8.93M -$1.22M -11,355 -12%
Aberdeen Group
91
Aberdeen Group
United Kingdom
$8.84M +$169K +1,569 +2%
SEI Investments
92
SEI Investments
Pennsylvania
$8.17M -$210K -1,950 -3%
Nordea Investment Management
93
Nordea Investment Management
Sweden
$8.16M -$6.57M -61,347 -45%
UBS Group
94
UBS Group
Switzerland
$8.07M -$3.19M -29,711 -28%
Axa
95
Axa
France
$7.96M +$7.96M +74,092 New
Russell Investments Group
96
Russell Investments Group
United Kingdom
$7.84M +$172K +1,605 +2%
WP
97
Woodline Partners
California
$7.69M +$7.69M +71,496 New
Barclays
98
Barclays
United Kingdom
$7.63M +$1.99M +18,501 +35%
RHJA
99
Rice Hall James & Associates
California
$7.19M +$576K +5,362 +9%
Fisher Asset Management
100
Fisher Asset Management
Washington
$7.18M -$672K -6,252 -9%
2 3
4
5 6